Ameritox was a company that provided physicians with urine drug monitoring and reporting services. Headquartered in Baltimore, Maryland, the company also had a CLIA-certified laboratory in Greensboro, North Carolina.
Ameritox offered urine drug testing and reporting services to help physicians determine if their chronic pain patients are taking their pain medications correctly. Physicians use this information to identify potential medication misuse and abuse, and make more informed decisions. Ameritox's customer service and patient management support tools permitted physicians to integrate medication monitoring into their practice.
Ameritox Ltd. was founded in 1996 in Midland, Texas as Universal Toxicology Laboratories (UTL), a federally certified drug testing facility and medical examiner toxicology laboratory.
UTL identified a growing need for a more detailed way of monitoring the use of long-term pain medications used by patients. The company became Ameritox Ltd. in 2003. Today, Ameritox claims to be the nation's largest provider of pain medication monitoring solutions for physicians.
In 2018 Ameritox sold is book of business, auctioned equipment and other assets, and ceased to operate.
Rx Guardian CD SM is now part of the Rx Guardian SM process. Rx Guardian CD SM features a unique reference database supported by a proprietary normalization algorithm. Patients’ normalized results are compared against the reference database, giving added confidence in assessing whether patients are taking their medications correctly.
In 2012, Ameritox launched the Rx Guardian INSIGHT Report, which, according to a press release, "provides a concise summary of the most important elements of a patient's medication monitoring results. It also helps clinicians assess a patient's medication adherence over time by showing a chronology of previous Rx Guardian CD(SM) standard scores."
Ameritox's clinical research program investigates topics related to managing patients on chronic opioid therapy.
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.